Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in ADCT — ADC Therapeutics SA

CIK 80255 BALTIMORE, MD
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$80,100
-$182,576 QoQ
Shares Held
74,860
+6.9% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 113 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $2,378,351,093 across 40 Drug Manufacturers - Specialty & Generic names. ADCT ranks #38 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 68,214,436 $1,083,245,243
2 ALKS
Alkermes plc.
 6,737,328 $353,035,986
3 LNTH
Lantheus Holdings, Inc.
 1,903,354 $211,158,092
4 LQDA
Liquidia Corp
 1,940,364 $154,705,221
5 UTHR
UNITED THERAPEUTICS Corp
 243,444 $131,905,262
6 PRGO
PERRIGO Co plc
 8,700,421 $90,397,373
7 ZTS
Zoetis Inc.
 1,139,097 $81,855,510
8 TEVA
Teva Pharmaceutical Industries Ltd
 1,679,152 $56,889,668

All Filings in ADCT

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $80,100 74,860
2026-03-31 $262,676 70,047
2025-12-31 $165,027 46,750
2025-09-30 $148,852 37,213
2025-06-30 $99,730 37,213
2025-03-31 $51,057 36,211
2024-12-31 $57,373 28,831
2024-09-30 $90,817 28,831
2024-06-30 $71,024 22,476
2023-06-30 $2,626,951 1,221,838
2023-03-31 $2,547,554 1,306,438
2022-12-31 $5,711,251 1,487,305
2022-09-30 $5,739,434 1,190,754
2022-06-30 $15,591,619 1,961,210
2022-03-31 $36,176,122 2,462,636
2021-12-31 $57,599,027 2,851,437
2021-09-30 $76,828,578 2,828,740
2021-06-30 $64,833,944 2,662,585
2021-03-31 $67,024,831 2,745,794
2020-12-31 $62,924,009 1,965,761
2020-09-30 $23,725,583 719,175
2020-06-30 $27,723,269 592,251